JFL Life, a company in the Pharmaceuticals industry, reported revenue of ₹99 crore and net profit of ₹4.23 crore for the September 2026 quarter.
JFL Life (NSE: JFLLIFE-SM) closed at ₹12.35 on 20 Nov 2026, up 0.4% over the past year. Its market capitalisation is ₹41 crore and it trades at 4.5 times earnings.
Incorporated in 2010, JFL Life Sciences Ltd produces and markets a wide range of formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.